AT
Aditya Tolia
Private Equity Senior Analyst
OrbiMed
Private Equity Senior Analyst at OrbiMed with prior Investec and PwC banking experience.
CG
Bio
Professional summary
Carl L. Gordon is a Managing Partner at OrbiMed and leads the firm's private equity team. He joined OrbiMed's predecessor firm in 1995 and was a founding General Partner of OrbiMed in 1998. His background includes ImClone Systems, a Ph.D. in Biology from MIT, and a postdoctoral fellowship at Rockefeller University; OrbiMed says he has founded and invested in numerous biotechnology companies and served on many public and private company boards.
Notable companies
Selected portfolio companies the partner has backed
GentiBioRayTheraADARx PharmaceuticalsBlossomHill Therapeutics
Background
Career, education, and skills
Career history
- OrbiMedManaging Partner1998 – Present
- Mehta and IsalySenior Biotechnology Analyst1995 – 1997
- Rockefeller UniversityPostdoctoral Fellow1993 – 1995
- ImClone SystemsEmployee1987 – 1988
Education
- Harvard UniversityA.B. in Chemistry & Physics1987
- Massachusetts Institute of TechnologyPh.D. in Biology1993
Other partners at OrbiMed
12 more profiles
Alexis Megibow
Private Equity Associate
OrbiMed
Private Equity Associate at OrbiMed.
Ankesh Bhansali
Managing Director
OrbiMed
OrbiMed Asia Managing Director focused on healthcare private equity.
Arun Sadhanandham
Managing Director
OrbiMed
OrbiMed Asia Managing Director investing in healthcare private equity.
BC
Brendan Weber, CFA
Principal
OrbiMed
Principal on OrbiMed's Credit & Royalty team focused on structured credit and royalty financings.
Carl L. Gordon
Managing Partner
OrbiMed
Carl L. Gordon is a Managing Partner at OrbiMed and leads the firm's private equity team.
CN
Carter Neild
Managing Partner
OrbiMed
OrbiMed Managing Partner focused on healthcare royalties and Asia private investments.
Clay Daniel DeMarcus
Principal
OrbiMed
Principal focused on medical technology and non-therapeutics venture investing.
CS
Cooper Steputis
Private Equity / Venture Capital
OrbiMed
Healthcare private equity and venture investor with prior investment banking experience.
Daniel Ying
Executive Director
OrbiMed
OrbiMed Asia Executive Director focused on pharma and biotech investments.
David Bonita
General Partner
OrbiMed
OrbiMed General Partner and physician-investor in healthcare and therapeutics.
David Wang
Partner
OrbiMed
OrbiMed Asia Partner focused on Greater China healthcare investments.